Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
462.00
-23.00 (-4.74%)
Mar 4, 2026, 1:35 PM CST
-38.41%
Market Cap 60.15B
Revenue (ttm) 21.10B
Net Income (ttm) 3.08B
Shares Out 124.02M
EPS (ttm) 24.04
PE Ratio 14.88
Forward PE 12.52
Dividend 11.67 (2.36%)
Ex-Dividend Date Jun 20, 2025
Volume 3,000
Average Volume 1,911,904
Open 482.00
Previous Close 485.00
Day's Range 462.00 - 482.00
52-Week Range 462.00 - 795.00
Beta 0.81
RSI 37.80
Earnings Date Mar 5, 2026

About Bora Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti... [Read more]

Sector Healthcare
Founded 2007
Employees 36
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6472
Full Company Profile

Financial Performance

In 2024, Bora Pharmaceuticals's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.

Financial Statements

News

There is no news available yet.